GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Cash Flow from Others

Gemina Laboratories (XCNQ:GLAB) Cash Flow from Others : C$-0.13 Mil (TTM As of Oct. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Cash Flow from Others?

Gemina Laboratories's cash flow from others for the three months ended in Oct. 2024 was C$0.05 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.13 Mil.


Gemina Laboratories Cash Flow from Others Historical Data

The historical data trend for Gemina Laboratories's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Cash Flow from Others Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Cash Flow from Others
- 0.01 0.01 0.05

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 -0.27 0.03 0.06 0.05

Gemina Laboratories Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.13 Mil.

Gemina Laboratories Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
Martin Cronin Director
John Davies Director, Director or Senior Officer of 10% Security Holder, Senior Officer
James Damian Tansey Director

Gemina Laboratories Headlines

No Headlines